Barclays’s Mead Johnson Nutrition Company MJN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-41,000
| Closed | -$3.65M | – | 7221 |
|
|
2017
Q1 | $3.65M | Buy |
41,000
+18,700
| +84% | +$1.54M | 0.01% | 1564 |
|
|
2016
Q4 | $1.58M | Buy |
22,300
+5,200
| +30% | +$388K | ﹤0.01% | 2321 |
|
|
2016
Q3 | $1.35M | Sell |
17,100
-3,000
| -15% | -$256K | ﹤0.01% | 2345 |
|
|
2016
Q2 | $1.82M | Sell |
20,100
-8,700
| -30% | -$737K | 0.01% | 2094 |
|
|
2016
Q1 | $2.42M | Sell |
28,800
-700
| -2% | -$52.1K | 0.01% | 1749 |
|
|
2015
Q4 | $2.3M | Sell |
29,500
-1,500
| -5% | -$118K | 0.01% | 1913 |
|
|
2015
Q3 | $2.17M | Buy |
31,000
+8,000
| +35% | +$658K | 0.01% | 2054 |
|
|
2015
Q2 | $2.07M | Buy |
23,000
+15,700
| +215% | +$1.51M | ﹤0.01% | 2196 |
|
|
2015
Q1 | $730K | Sell |
7,300
-122,700
| -94% | -$12.4M | ﹤0.01% | 3257 |
|
|
2014
Q4 | $13M | Sell |
130,000
-92,300
| -42% | -$9.2M | 0.02% | 1016 |
|
|
2014
Q3 | $21.3M | Buy |
222,300
+115,000
| +107% | +$10.9M | 0.04% | 684 |
|
|
2014
Q2 | $9.98M | Buy |
107,300
+77,900
| +265% | +$6.81M | 0.02% | 1159 |
|
|
2014
Q1 | $2.44M | Sell |
29,400
-73,300
| -71% | -$5.94M | ﹤0.01% | 2357 |
|
|
2013
Q4 | $8.52M | Buy |
102,700
+17,000
| +20% | +$1.38M | 0.02% | 1374 |
|
|
2013
Q3 | $6.34M | Sell |
85,700
-53,800
| -39% | -$4.03M | 0.02% | 1492 |
|
|
2013
Q2 | $11.1M | Buy |
+139,500
| New | +$11.2M | 0.03% | 1014 |
|
Other funds holding MJN
PAMU
GT
FNBOO
LFAS
CPIG
WEC